(Q48250542)

10 February 2018

title

Delayed neuroprotection induced by sevoflurane via opening mitochondrial ATP-sensitive potassium channels and p38 MAPK phosphorylation. (English)

1 reference

10 February 2018

1 reference

Zhi Ye

1

1 reference

10 February 2018

Qulian Guo

2

1 reference

10 February 2018

Na Wang

3

1 reference

10 February 2018

Pingping Xia

4

1 reference

10 February 2018

Yajing Yuan

5

1 reference

10 February 2018

E Wang

6

1 reference

10 February 2018

publication date

1 July 2011

1 reference

10 February 2018

published in

Neurological Sciences

1 reference

10 February 2018

volume

33

1 reference

10 February 2018

page(s)

239-249

1 reference

10 February 2018

issue

2

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1007/s10072-011-0665-6

exact match

0 references

cites work

Sevoflurane immediate preconditioning alters hypoxic membrane potential changes in rat hippocampal slices and improves recovery of CA1 pyramidal cells after hypoxia and global cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Isoflurane induces a protein kinase C alpha-dependent increase in cell-surface protein level and activity of glutamate transporter type 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Isoflurane preconditioning increases B-cell lymphoma-2 expression and reduces cytochrome c release from the mitochondria in the ischemic penumbra of rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible NO synthase dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Isoflurane preconditioning induces neuroprotection against ischemia via activation of P38 mitogen-activated protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Sevoflurane preconditioning against focal cerebral ischemia: inhibition of apoptosis in the face of transient improvement of neurological outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

The preconditioning effect of sevoflurane on the oxygen glucose-deprived hippocampal slice: the role of tyrosine kinases and duration of ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Improved mitochondrial bioenergetics by anesthetic preconditioning during and after 2 hours of 27 degrees C ischemia in isolated hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Isoflurane activates human cardiac mitochondrial adenosine triphosphate-sensitive K+ channels reconstituted in lipid bilayers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Preconditioning by isoflurane retains its protection against ischemia-reperfusion injury in postinfarct remodeled rat hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Sevoflurane confers additional cardioprotection after ischemic late preconditioning in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Sevoflurane depolarizes pre-synaptic mitochondria in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Diversity in function and regulation of MAP kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Increased brain injury and vascular leakage after pretreatment with p38-inhibitor SB203580 in transient ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Preconditioning by an in situ administration of hydrogen peroxide: involvement of reactive oxygen species and mitochondrial ATP-dependent potassium channel in a cerebral ischemia-reperfusion model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Sevoflurane pre- and post-conditioning protect the brain via the mitochondrial K ATP channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Isoflurane tolerance against focal cerebral ischemia is attenuated by adenosine A1 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Ischemic postconditioning inhibits apoptosis after focal cerebral ischemia/reperfusion injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Sevoflurane-induced preconditioning of rat brain in vitro and the role of KATP channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Sevoflurane-induced preconditioning protects against cerebral ischemic neuronal damage in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Activation of p38 kinase in the gerbil hippocampus showing ischemic tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-epsilon and p38 MAPK

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

The p38 MAPK inhibitor, SB203580, abrogates ischaemic preconditioning in rat heart but timing of administration is critical.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Cell type-specific activation of p38 MAPK in the brain regions of hypoxic preconditioned mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Limb ischemic preconditioning induces brain ischemic tolerance via p38 MAPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Mitochondria-derived reactive oxygen species and vascular MAP kinases: comparison of angiotensin II and diazoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Role of the p38 mitogen-activated protein kinase/cytosolic phospholipase A2 signaling pathway in blood-brain barrier disruption after focal cerebral ischemia and reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Glutamate-induced toxicity in hippocampal slices involves apoptotic features and p38 MAPK signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

p38alpha MAP kinase mediates hypoxia-induced motor neuron cell death: a potential target of minocycline's neuroprotective action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

K(ATP) channel-independent targets of diazoxide and 5-hydroxydecanoate in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Inhibition of the mitochondrial KATP channel by long-chain acyl-CoA esters and activation by guanine nucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Beta-oxidation of 5-hydroxydecanoate, a putative blocker of mitochondrial ATP-sensitive potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Involvement of mitochondrial K+ release and cellular efflux in ischemic and apoptotic neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Diazoxide preconditioning attenuates global cerebral ischemia-induced blood-brain barrier permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Preconditioning with sevoflurane reduces changes in nicotinamide adenine dinucleotide during ischemia-reperfusion in isolated hearts: reversal by 5-hydroxydecanoic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0665-6

Mitogen-activated protein kinases mediate heat shock-induced delayed protection in mouse heart.

21 January 2018

1 reference

12 December 2020

Adenosine-induced late preconditioning in mouse hearts: role of p38 MAP kinase and mitochondrial K(ATP) channels

1 reference

12 December 2020

Adenosine A(1) receptor induced delayed preconditioning in rabbits: induction of p38 mitogen-activated protein kinase activation and Hsp27 phosphorylation via a tyrosine kinase- and protein kinase C-dependent mechanism

1 reference

12 December 2020

Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human

1 reference

12 December 2020

Systemic administration of diazoxide induces delayed preconditioning against transient focal cerebral ischemia in rats

1 reference

12 December 2020

SAPKs regulation of ischemic preconditioning

1 reference

12 December 2020

Preconditioning with isoflurane produces dose-dependent neuroprotection via activation of adenosine triphosphate-regulated potassium channels after focal cerebral ischemia in rats

1 reference

12 December 2020

State-dependent inhibition of the mitochondrial KATP channel by glyburide and 5-hydroxydecanoate

1 reference

12 December 2020

SB 203580, an inhibitor of p38 MAPK, abolishes infarct-limiting effect of ischemic preconditioning in isolated rabbit hearts

1 reference

12 December 2020

10.1007/S10072-011-0665-6

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

21720900

1 reference

10 February 2018